Called Coartem, it combines a derivative of artemisinin, an extract from sweet wormwood bush, with a second drug, lumefantrine.

FORBES: Fighting Malaria

But the only firm that achieved any success was Novartis, which in 1998 developed Coartem, an antimalarial drug that combines artemisinin, an extract from the sweet wormwood plant, with a compound called lumefantrine.

FORBES: Magazine Article